CFCT exhibited dose- and time-dependent cytotoxicities against A549 and SGC-7901 cells with the IC50
values of 30.2 and 65.7 μg/mL, respectively. Furthermore, CFCT at a dose of 50 or 100 mg/kg could significantly in-
hibit the tumor growth in vivo and prolonged the survival time in two different models as compared with the
model group, especially when combined with the CTX at a low dose rate. And it also increased spleen index of
Kunming mice and thymus index of C57BL/6 mice. Meanwhile, histologic analysis illustrated that CFCT alone or in
combination with CTX could induce tumor tissue necrosis of both models. In addition, CFCT at a dose of 50 or
100 mg/kg inhibited the lung metastasis of melanoma B16F10 in tumor-bearing C57BL/6 mice. The antimetastatic
effect was also observed when CFCT was used in combination with CTX. In comparison to any other groups, CFCT
at a dose of 100 mg/kg could effectively enhance the GSH-Px activities of various tissues in tumor-bearing C57BL/6
mice.